Aims-To substantiate the high incidence of monocyte esterase deficiency (MED) longer disease free survival in the MED cohort and increased occurrence of benign neoplasms-largely colorectal polyps-in this group also. Three patients had a borderline degree of deficiency and were excluded from comparisons, although they showed the same clinical tendencies as the MED group.
in esterase deficient and esterase positive patients. Methods-Peripheral blood smears (n = 22) or cytocentrifuge preparations (n = 52) of mononuclear cells from the peripheral blood of patients with gastrointestinal carcinoma were stained by the non-specific esterase stain (pH 5.8) using a batch technique. Samples containing > 85% esterase negative monocytes were identified at light microscopic examination. Results-Seven of 74 patients were identified as having MED. This correlated exactly with the proportion (five of 46) found before, using an automated method, and was significantly higher than the 0-8% incidence in normal blood donors shown in that study. Comparison of the clinical details of the 12 MED patients with those of 105 esterase positive patients showed a significantly longer disease free survival in the MED cohort and increased occurrence of benign neoplasms-largely colorectal polyps-in this group also. Three patients had a borderline degree of deficiency and were excluded from comparisons, although they showed the same clinical tendencies as the MED group. Conclusions-There is a strong degree of association between monocyte esterase deficiency and gastrointestinal carcinoma. Further evidence must be sought to prove that the deficiency precedes the disease and therefore may predispose to it, or at least may identify subjects with such a predisposition. This could lead to early diagnosis and effective treatment of gastrointestinal carcinoma in a sizeable proportion of patients. Screening procedures for early detection of large bowel cancer in the families of subjects with familial adenomatous polyposis reduce early mortality from this cancer. The prevalence of the APC gene is variously estimated at 1 in 5000 to 1 in 20 000. Monocyte esterase deficiency (MED) occurs in 0 8%1 "or 'less than 1 %' of normal individuals" (Technicon Manual, Technicon Instruments Corp, Tarrytown, New York). In 46 patients with gastrointestinal carcinoma the deficiency was shown in five.' It has been suggested that MED, whether constitutional'2 or acquired,' results in, or is linked to, a predisposition to lymphoproliferative neoplasia. A similar link with gastrointestinal cancer could indicate a putative relative risk of 14 3 (95% confidence limits 3, 67)4 for gastrointestinal cancer in MED subjects. In that case it would be useful to identify esterase deficient subjects to monitor the development of gastrointestinal malignancy with a view to early resection.
The original association of MED with gastrointestinal carcinoma was found in a small group of 456 patients with various carcinomata. The purpose of the present study was to examine a greater number of patients with gastrointestinal carcinoma for MED to ensure that the original finding was not a false positive result due to a type I error from examination of multiple subgroups. A second reason was to identify a larger number of such patients with and without esterase deficiency so that their clinical details could be compared.
Methods
Blood samples were obtained from 74 patients with gastrointestinal cancer confirmed by histological examination. The patients were sampled at random depending on pressure of work on the surgeon concerned and the haematology department, as well as the consent of the patient. The (CI 5-17% ). These incidences were significantly increased when compared with the 0 8% (CI 0-2-2 1%) incidence of the deficiency already shown in 474 blood donors (p < 0 001 in each case; Fisher's exact test).' There was no material change in the degree of MED noted in the repeat samples obtained from seven MED patients.
Two patients examined by the cytospin method were difficult to categorise even after several stains not consistently quite fulfilling the >85% negative criterion. These patients were segregated into an intermediate group with a third patient previously identified as having 80% esterase negative monocytes by the Haemalog D 90. This group has been kept separate and is not included in comparisons of MED patients with esterase positive patients.
In table 2 the occurrence of MED according to primary site of neoplasm is shown together with some variables of MED and esterase positive cohorts. There was no significant difference between the two cohorts for any of these.
MED occurred as often in patients who were apparently free of tumour at the time of analysis as in patients in whom tumour was present (table 3) . Of the 73 esterase positive patients with tumours, esterase analysis was performed preoperatively in 20; 37 were analysed postoperatively but their disease had The three female patients were old age pensioners when esterase analysis was performed; no previous employment was recorded for any of them. Three male 
Discussion
This study showed that the original finding of an association between MED and gastrointestinal carcinoma was not a type I error. There is a substantially increased incidence of MED in such patients. Although manual methods were used in the present study, the degree of control incorporated in it and the reference to the same standard as that used in the original one-that is, the patient with repeated demonstration of > 85% esterase negative monocytes-validated the comparison of results from the two studies.
We considered as MED only samples showing >85% esterase negative monocytes by the cytospin method or the comparable R/M of the Haemalog D-90, because such samples have been shown to lack the monocyte specific isoenzyme band on isoelectric focusing.2 Study of the intermediate group, however, identified in the present study, suggests that monocyte esterase deficiency of a lesser degree may be important.
The occurrence of the anomaly was not related to the age of the patient, tumour status at time of esterase analysis, resection, stage of disease at presentation, or primary site of neoplasm in the gastrointestinal tract. That exposure of blood to organophosphates in vitro inhibits monocyte esterase is well documented. In vivo inhibition has only been documented in two studies to our knowledge. Oehmichen et al described its occurrence in a patient who swallowed organophosphate insecticide,6 and Mandel et al demonstrated a 22% reduction of monocyte esterase activity in workers exposed to organophosphates,7 while workers elsewhere in the plant did not show a decrease. Levine et al described a 72% reduction in monocyte esterase activity in a group of production workers at a plastics manufacturing company but did not positively identify organophosphate as the causative agent, although this seemed likely. 8 Again, other workers at the plant did not show a reduction. The occupations of our patients at the time of esterase analysis show that such a degree of exposure to organophosphates is unlikely to have occurred in our MED patients. Moreover, the stability of the MED, as evidenced by its presence in repeat samples many weeks after the first sample, further indicates that such exposure cannot be implicated as the cause of the deficiency in our series. The patient described by Oehmichen et al regained monocyte esterase activity 15 days after the poisoning episode, indicating that newly produced monocytes retained the capacity to form monocyte esterase, although the enzyme itself is irreversibly inhibited by organophosphates. In MED patients with lymphoproliferative or autoimmune diseases we have shown a high familial incidence of the deficiency."'30 The lack of a demonstrable acquired cause for the deficiency in the present study raises the possibility that it could be constitutional in this instance as well.
We have already suggested that MED may result in, or be linked to, a predisposition to lymphoproliferative disease.3"0 This was based on the demonstration of a defect in natural cytotoxicity of esterase negative'0 or esterase inhibited" monocytes, and on the demonstration of an increased incidence of familial MED in lymphoproliferative neoplasia. If MED in patients with gastrointestinal carcinoma were constitutional then screening for the deficiency should identify a large cohort at risk for this cancer. Moreover, MED subjects may have diminished ability to detoxify organophosphates and possibly, therefore may be at risk from the mutagenic effect of the latter and so could be advised to avoid exposure to these substances.
As only 12 MED patients were identified, no firm conclusions can be drawn from the comparisons of MED and esterase positive patients. On the one hand, lack of association of the deficiency with earlier age at presentation of disease and lack of association with family history of neoplasia could challenge the hypothesis of a predisposition to neoplasia. On the other hand, the tentatively increased incidence of benign tumours, known to be linked to colonic carcinoma, and the tendency to longer survival (analogous with that of familial colonic carcinoma) of the MED cohort could corroborate it. We suggest that a comprehensive study, incorporating screening for MED both in patients and their close relatives, together with detailed occupational histories and full investigation into the occurrence of cancer within families, should be undertaken to test the hypothesis.
The lack of a simple screening procedure for monocyte esterase deficiency poses a considerable difficulty. The method used for this study is too cumbersome for screening large numbers of patients; the Haemalog D-90 automated cytochemistry analyser has been replaced by improved instruments which, however, lack the esterase channel, and, because inactive isoenzyme seems to be present in MED subjects (personal communication, Dr K Ennis, Department of Medical Genetics, Queens University Belfast), antibody screening methods will not detect the deficiency state unless an antibody to the active site is produced. The semi-automated method of Ross et al'2 should permit identification of the deficiency state, but it is clear that a fully automated screening procedure would greatly simplify the proposed investigation.
